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Summary
Objective: To determine whether smoking affects knee cartilage in healthy adults by examining the association of tobacco use with tibial car-
tilage volume and tibiofemoral cartilage defects.
Methods: Two hundred and ninety-seven healthy adult subjects were recruited from an existing cohort examining healthy aging, the Mel-
bourne Collaborative Cohort Study (MCCS). Questionnaire data were obtained at recruitment to the MCCS in 1990e1994 and at magnetic
resonance imaging to determine cartilage outcomes in 2003.
Results: Tibial cartilage volume was positively associated with subjects who ever smoked as well as pack-years smoked, suggesting a dosee
response. There was no association between smoking and presence of tibiofemoral cartilage defects.
Conclusion: Our ﬁndings demonstrate that smoking is associated with increased tibial cartilage volume but not presence of tibiofemoral car-
tilage defects, providing further support for a beneﬁcial effect on articular knee cartilage.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





Previous studies suggest that smoking reduces the risk of
knee osteoarthritis (OA) with in vitro data indicating
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2006.58a beneﬁcial effect of nicotine on chondrocyte function1e3.
As a possible explanation for these ﬁndings, a recent study
showed that nicotine upregulates glycosaminoglycan and
collagen synthetic activity of articular chondrocytes in
a dose-dependent manner and at physiological levels
seen for individuals who smoke3. These data suggested
that any ‘protective’ effect of smoking on OA may be related
to altered chondrocyte metabolism.
Prior studies used radiology to compare people with OA
to those with no disease. Recent developments in knee im-
aging, using magnetic resonance imaging (MRI) have made
it possible to examine cartilage within the knee joint non-in-
vasively as a continuum from a normal to an osteoarthritic
joint4,5. Loss of cartilage volume has been shown to be
a risk factor for joint replacement and knee symptoms6,7.
Cartilage defects are predictors of cartilage loss in healthy
people with no knee symptoms or radiological OA8. Our
aim was to determine whether smoking affects knee carti-
lage in healthy adults by examining the association with car-
tilage volume and defects using MRI.7
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SUBJECTS
Study subjects were recruited from an existing cohort:
Melbourne Collaborative Cohort Study (MCCS), a prospec-
tive cohort study of community-based people, aged 40e69
years at recruitment (1990e1994); with the aim of examin-
ing the role of lifestyle and genetic factors in the risk of can-
cer and chronic diseases from middle age and beyond9.
As our intent was to investigate subjects with no signiﬁcant
current or past knee disease, individuals were excluded if in
the last 5 years, they had knee pain lasting for>24 h; a previ-
ous knee injury requiring non-weight bearing treatment for
>24 h or surgery (including arthroscopy); or a history of any
arthritis diagnosed by a medical practitioner. A further exclu-
sion criterion was a contraindication to MRI. We invited sub-
jects who fulﬁlled our inclusion criteria and attended the ﬁrst
year of round 3 follow-up of the MCCS which commenced
in 2003. We used quota sampling whereby recruitment
ceased when our target sample of approximately 300 sub-
jects was achieved. The study was approved by The Cancer
Council of Victoria Human Research Ethics Committee. All
participants gave written informed consent.
SMOKING AND ANTHROPOMETRIC DATA
At recruitment to the MCCS in 1990e1994, a baseline
questionnaire was completed that included demographic
data and lifestyle factors including tobacco use. A similar
questionnaire was readministered at the time of MRI in
2003. Height and weight were measured and body mass in-
dex (BMI) calculated. Subjects were classiﬁed as having
‘ever smoked’ if they reported smoking at least seven ciga-
rettes or seven pipes of tobacco per week for at least 1
year. If subjects did not consume this amount, they were
classiﬁed as having ‘‘never smoked’’.
MRI AND THE MEASUREMENT OF CARTILAGE VOLUME
AND CARTILAGE DEFECTS
MRI was performed on the dominant knee as previously
described5. The following sequence and parameters were
used: a T1-weighted fat suppressed three dimensional
(3D) gradient recall acquisition in the steady state; ﬂip angle
55; repetition time 58 ms; echo time 12 ms; ﬁeld of view16 cm; 60 partitions; 512 (frequency direction, superi-
oreinferior) 512 (phase encoding direction, anteriorepos-
terior) matrix; one acquisition, time 11 min 56 s. Sagittal
images were obtained at a partition thickness of 1.5 mm
and an in-plane resolution of 0.31 mm 0.31 mm
(512 512 pixels).
Tibial cartilage volume was determined by image process-
ing on an independent workstation using the Osiris software
(Geneva, Switzerland) as reported previously4,5. The vol-
umes of the tibial cartilagewere isolated from the total volume
by manually drawing disarticulation contours around the car-
tilage boundaries oneach section. The coefﬁcient of variation
(CV) for the tibial cartilage volume was 2.2%4. Tibial bone
area was determined by creating an isotropic volume from
the input images that were reformatted in the axial plane
and directly measured from these images. CV for tibial
bone area was 2.4%4. Tibiofemoral cartilage defects were
graded on the MR images with a classiﬁcation system that
has beenpreviously described10. Intraobserver reliability (ex-
pressedas intraclass correlation coefﬁcient, ICC)was0.8510.
STATISTICAL ANALYSES
Tibial cartilage volume was approximately normally dis-
tributed and analyzed using linear regression. Logistic re-
gression was used for the analysis of the presence of any
cartilage defects vs no defects as the distribution of carti-
lage defects was not normally distributed. Multivariate
models were constructed to estimate the relationship be-
tween smoking and the outcome measures (cartilage vol-
ume and defects) with adjustment for age, gender, BMI
and tibial bone area (for cartilage volume analysis). The pri-
mary analysis was based upon ever (i.e., former and cur-
rent) smoking and pack years of smoking as reported at
the time of the MRI. The pack-year variable was calculated
by averaging the number of cigarettes smoked daily, divid-
ing by 20 (considered one pack) and multiplying by the
number of years smoked11. All analyses were performed
using the SPSS statistical package (standard version
14.0, SPSS, Chicago, IL).
RELATIONSHIP BETWEEN SMOKING AND KNEE CARTILAGE
The characteristics of the 297 participants are presented
in Table I. There were 118 (40%) subjects who reportedTable I
Subject characteristics*
Total (n¼ 297) Smokers (former/current) Non-smokers (never) P value
At recruitment (1990e1994)
No. of females (%) 186 (63) 73 (62) 113 (63) 0.83z
Height (cm) 168.1 (9.0) 167.9 (8.8) 168.2 (9.2) 0.77
Weight (kg) 71.3 (13.3) 70.7 (13.8) 71.7 (12.9) 0.54
BMI (kgm2) 25.2 (3.8) 24.9 (3.6) 25.3 (4.0) 0.42
No. of subjects ever smoked ‘‘yes’’ (%) 118 (40) 118 0 e
Amount of pack years 5.9 (11.6)y 5.9 (11.6)y e e
At MRI (2003)
Age (years) 58.0 (5.5) 58.6 (6.2) 57.5 (4.9) 0.08
No. of females (%) 186 (63) 76 (61) 110 (64) 0.69z
No. of subjects ever smoked ‘‘yes’’ (%) 124 (42) 124 0 e
Amount of pack years 6.3 (12.5)y 6.3 (12.5)y e e
Tibial cartilage volume (mm3) 3731 (1116) 3875 (1152) 3629 (1081) 0.06
Presence of tibiofemoral cartilage defects (%) 184 (62.0) 80 (64.5) 104 (60.1) 0.44z
*Values are reported as mean (SD), except where otherwise speciﬁed.
yMissing data for two subjects who smoked.
zPearson Chi square for dichotomous variable.
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Tibial cartilage volume (mm3) 246 (11, 503)* 0.06 175 (28, 322)* 0.02
Presence of tibiofemoral cartilage defects 1.2 (0.7, 1.9)y 0.44 1.2 (0.7, 2.0)y 0.47
Amount of pack-years smokedz
Tibial cartilage volume (mm3) 11.8 (1.6, 22.0)* 0.02 6.7 (0.8, 12.6)* 0.03
Presence of tibiofemoral cartilage defects 1.0 (0.99, 1.02)y 0.65 1.0 (0.98, 1.02)y 0.71
*Increment in cartilage volume (mm3) if ever smoked or per unit pack-year smoked in univariate analysis and after adjusting for age, gender,
baseline BMI and tibial bone area in multivariate analysis.
yOdds ratio of cartilage defect being present if ever smoked or per unit pack-year smoked in univariate analysis and after adjusting for age,
gender and baseline BMI in multivariate analysis.
zMissing data for two subjects who smoked.ever smoking in 1990e1994 and 124 (42%) at the time of
MRI during 2003 (Kappa 0.92, P< 0.001). Twelve (4%)
subjects smoked in 2003, nine had continued to smoke
throughout the 10 years, three former smokers had recom-
menced smoking, and 12 subjects had ceased smoking by
2003. There were no signiﬁcant differences in demographic
variables between former or current smokers and non-
smokers, although non-smokers tended to be younger
(P¼ 0.08) and have less tibial cartilage (P¼ 0.06).
After adjusting for age, gender, BMI and tibial bone area,
the mean tibial cartilage volume was 175 mm3 (95% conﬁ-
dence interval (CI) 28, 322) greater for ‘ever’ smokers
than for those who had never smoked (Table II). There
was a positive association that suggested a doseeresponse
between the number of pack-years smoked and tibial carti-
lage volume [regression coefﬁcient: b¼ 6.7 mm3 per pack
year (95% CI 0.8, 12.6)]. There was no association between
‘ever’ smoking, or pack-years of smoking, and tibiofemoral
cartilage defects. When we analyzed smoking data from
baseline (approximately 10 years prior to MRI), similar re-
sults were obtained: tibial cartilage volume vs ‘ever’ smoked
[b¼ 206 (95% CI 59, 352), P¼ 0.006]; and pack-years
smoked [b¼ 6.6 (95% CI 0.3, 13), P¼ 0.04]; there were
also no associations with tibiofemoral cartilage defects (re-
sults not shown).
In this healthy population, we found that smoking was as-
sociated with an increase in tibial cartilage volume but not
with the presence of cartilage defects. Furthermore, there
was a positive association that suggested a doseeresponse
between pack-years of smoking and cartilage volume. Thus
our study supports previous reports of a protective effect of
smoking on the risk of knee OA1,2. The association is not an
artifact of a cross-sectional design, since similar results
were found when the smoking level 10 years prior to the
MRI was examined.
There is some evidence that the mechanism for any
protective effect of smoking would be mediated through
nicotine enhancing chondrocyte metabolism of proteins, in-
creasing collagen3 and GAG synthesis12. While it is not
suggested that smoking be used as a means of therapeutic
intervention in OA, as was the case with ulcerative coli-
tis13,14, investigating tobacco use may elucidate underlying
pathogenic mechanisms causing OA as well as clarify
the speciﬁc agents providing a chondro-protective effect.
Further studies may then provide feasible therapeutic inter-
ventions for OA, a disease with currently few effective ther-
apeutic alternatives15.References
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